Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery

The development of drug carriers based in lipid nanoparticles (LNPs) aims toward the synthesis of non-toxic multifunctional nanovehicles that can bypass the immune system and allow specific site targeting, controlled release and complete degradation of the carrier components. Among label free techni...

Full description

Bibliographic Details
Main Authors: Cecilia Yamil Chain, María Antonieta Daza Millone, José Sebastián Cisneros, Eduardo Alejandro Ramirez, María Elena Vela
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2020.605307/full
id doaj-061820607cbe4ee286630c88866e772c
record_format Article
spelling doaj-061820607cbe4ee286630c88866e772c2021-01-07T06:33:40ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462021-01-01810.3389/fchem.2020.605307605307Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug DeliveryCecilia Yamil ChainMaría Antonieta Daza MilloneJosé Sebastián CisnerosEduardo Alejandro RamirezMaría Elena VelaThe development of drug carriers based in lipid nanoparticles (LNPs) aims toward the synthesis of non-toxic multifunctional nanovehicles that can bypass the immune system and allow specific site targeting, controlled release and complete degradation of the carrier components. Among label free techniques, Surface Plasmon Resonance (SPR) biosensing is a versatile tool to study LNPs in the field of nanotherapeutics research. SPR, widely used for the analysis of molecular interactions, is based on the immobilization of one of the interacting partners to the sensor surface, which can be easily achieved in the case of LNPs by hydrophobic attachment onto commercial lipid- capture sensor chips. In the last years SPR technology has emerged as an interesting strategy for studying molecular aspects of drug delivery that determines the efficacy of the nanotherapeutical such as LNPs' interactions with biological targets, with serum proteins and with tumor extracelullar matrix. Moreover, SPR has contributed to the obtention and characterization of LNPs, gathering information about the interplay between components of the formulations, their response to organic molecules and, more recently, the quantification and molecular characterization of exosomes. By the combination of available sensor platforms, assay quickness and straight forward platform adaptation for new carrier systems, SPR is becoming a high throughput technique for LNPs' characterization and analysis.https://www.frontiersin.org/articles/10.3389/fchem.2020.605307/fulllipid nanoparticlesdrug carriersSurface Plasmon Resonancemolecular targetprotein corona
collection DOAJ
language English
format Article
sources DOAJ
author Cecilia Yamil Chain
María Antonieta Daza Millone
José Sebastián Cisneros
Eduardo Alejandro Ramirez
María Elena Vela
spellingShingle Cecilia Yamil Chain
María Antonieta Daza Millone
José Sebastián Cisneros
Eduardo Alejandro Ramirez
María Elena Vela
Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery
Frontiers in Chemistry
lipid nanoparticles
drug carriers
Surface Plasmon Resonance
molecular target
protein corona
author_facet Cecilia Yamil Chain
María Antonieta Daza Millone
José Sebastián Cisneros
Eduardo Alejandro Ramirez
María Elena Vela
author_sort Cecilia Yamil Chain
title Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery
title_short Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery
title_full Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery
title_fullStr Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery
title_full_unstemmed Surface Plasmon Resonance as a Characterization Tool for Lipid Nanoparticles Used in Drug Delivery
title_sort surface plasmon resonance as a characterization tool for lipid nanoparticles used in drug delivery
publisher Frontiers Media S.A.
series Frontiers in Chemistry
issn 2296-2646
publishDate 2021-01-01
description The development of drug carriers based in lipid nanoparticles (LNPs) aims toward the synthesis of non-toxic multifunctional nanovehicles that can bypass the immune system and allow specific site targeting, controlled release and complete degradation of the carrier components. Among label free techniques, Surface Plasmon Resonance (SPR) biosensing is a versatile tool to study LNPs in the field of nanotherapeutics research. SPR, widely used for the analysis of molecular interactions, is based on the immobilization of one of the interacting partners to the sensor surface, which can be easily achieved in the case of LNPs by hydrophobic attachment onto commercial lipid- capture sensor chips. In the last years SPR technology has emerged as an interesting strategy for studying molecular aspects of drug delivery that determines the efficacy of the nanotherapeutical such as LNPs' interactions with biological targets, with serum proteins and with tumor extracelullar matrix. Moreover, SPR has contributed to the obtention and characterization of LNPs, gathering information about the interplay between components of the formulations, their response to organic molecules and, more recently, the quantification and molecular characterization of exosomes. By the combination of available sensor platforms, assay quickness and straight forward platform adaptation for new carrier systems, SPR is becoming a high throughput technique for LNPs' characterization and analysis.
topic lipid nanoparticles
drug carriers
Surface Plasmon Resonance
molecular target
protein corona
url https://www.frontiersin.org/articles/10.3389/fchem.2020.605307/full
work_keys_str_mv AT ceciliayamilchain surfaceplasmonresonanceasacharacterizationtoolforlipidnanoparticlesusedindrugdelivery
AT mariaantonietadazamillone surfaceplasmonresonanceasacharacterizationtoolforlipidnanoparticlesusedindrugdelivery
AT josesebastiancisneros surfaceplasmonresonanceasacharacterizationtoolforlipidnanoparticlesusedindrugdelivery
AT eduardoalejandroramirez surfaceplasmonresonanceasacharacterizationtoolforlipidnanoparticlesusedindrugdelivery
AT mariaelenavela surfaceplasmonresonanceasacharacterizationtoolforlipidnanoparticlesusedindrugdelivery
_version_ 1724346716295004160